{
    "root": "aafede6f-f4c9-496c-9473-90679326e798",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Ergocalciferol",
    "value": "20250204",
    "ingredients": [
        {
            "name": "SOYBEAN OIL",
            "code": "241ATL177A",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_166975"
        },
        {
            "name": "GELATIN, UNSPECIFIED",
            "code": "2G86QN327L",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_5291"
        },
        {
            "name": "GLYCERIN",
            "code": "PDC6A3C0OX",
            "drugbank_id": "https://go.drugbank.com/drugs/DB09462"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_15377"
        },
        {
            "name": "D&C YELLOW NO. 10",
            "code": "35SW5USQ3G"
        },
        {
            "name": "FD&C BLUE NO. 1",
            "code": "H3R47K3TBD"
        },
        {
            "name": "ERGOCALCIFEROL",
            "code": "VS041H42XC",
            "drugbank_id": "https://go.drugbank.com/drugs/DB00153"
        }
    ],
    "indications": {
        "text": "ergocalciferol indicated treatment hypoparathyroidism , refractory rickets , also known vitamin resistant rickets , familial hypophosphatemia .",
        "doid_entities": [
            {
                "text": "hypoparathyroidism (DOID:11199)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_11199"
            },
            {
                "text": "rickets (DOID:10609)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_10609"
            },
            {
                "text": "hypophosphatemia (DOID:0050336)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_0050336"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "range therapeutic toxic doses narrow . vitamin resistant rickets:12,000 500,000 usp units daily . hypoparathyroidism:50,000 200,000 usp units daily concomitantly calcium lactate 4 g , six times per day . must individualized close medical supervision . calcium intake adequate . blood calcium phosphorous determinations must made every 2 weeks frequently necessary . x-rays bones taken every month condition corrected stabilized .",
        "doid_entities": [
            {
                "text": "rickets (DOID:10609)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_10609"
            },
            {
                "text": "hypoparathyroidism (DOID:11199)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_11199"
            }
        ],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "green , oval softgel imprinted pa140 contains 1,250 mcg ( 50,000 usp units vitamin ) ergocalciferol , usp . ndc 72162-1918-1 : 100 capsules bottle store 25\u00b0 c ( 77\u00b0 f ) ; excursions permitted 15\u00b0 30\u00b0 c ( 59\u00b0 86\u00b0 f ) [ usp controlled room temperature ] . protect light moisture . dispense tight , light-resistant container defined usp . repackaged/relabeled : bryant ranch prepack , inc.burbank , ca 91504",
    "adverseReactions": "ergocalciferol contraindicated patients hypercalcemia , malabsorption syndrome , abnormal sensitivity toxic effects vitamin , hypervitaminosis .",
    "indications_original": "Ergocalciferol is indicated for use in the treatment of hypoparathyroidism, refractory rickets, also known as vitamin D resistant rickets, and familial hypophosphatemia.",
    "contraindications_original": "THE RANGE BETWEEN THERAPEUTIC AND TOXIC DOSES IS NARROW.\n                  \n                     Vitamin D Resistant Rickets:12,000 to 500,000 USP units daily.\n\n \n                  \n                     Hypoparathyroidism:50,000 to 200,000 USP units daily concomitantly with calcium lactate 4 g, six times per day.\n\n \n                  DOSAGE MUST BE INDIVIDUALIZED UNDER CLOSE MEDICAL SUPERVISION.\n                  Calcium intake should be adequate. Blood calcium and phosphorous determinations must be made every 2 weeks or more frequently if necessary. X-rays of the bones should be taken every month until condition is corrected and stabilized.",
    "warningsAndPrecautions_original": "Each green, oval softgel is imprinted with PA140 and contains 1,250 mcg (50,000 USP units vitamin D) of ergocalciferol, USP.\n                  \n                     NDC 72162-1918-1: 100 Capsules in a BOTTLE\n                  \n                  Store at 25\u00b0 C (77\u00b0 F); excursions permitted to 15\u00b0 to 30\u00b0 C (59\u00b0 to 86\u00b0 F) [See USP Controlled Room Temperature].\n                  Protect from light and moisture.\n                  Dispense in a tight, light-resistant container as defined in the USP.\n                  Repackaged/Relabeled by:Bryant Ranch Prepack, Inc.Burbank, CA 91504",
    "adverseReactions_original": "Ergocalciferol is contraindicated in patients with hypercalcemia, malabsorption syndrome, abnormal sensitivity to the toxic effects of vitamin D, and hypervitaminosis D.",
    "drug": [
        {
            "name": "Ergocalciferol",
            "drugbank_id": "https://go.drugbank.com/drugs/DB00153"
        }
    ]
}